Global Testosterone Replacement Therapy Market Insights and Forecast to 2028

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Market Analysis and Insights: Global Testosterone Replacement Therapy Market
Due to the COVID-19 pandemic, the global Testosterone Replacement Therapy market size is estimated to be worth US$ 1458.6 million in 2022 and is forecast to a readjusted size of US$ 1134.6 million by 2028 with a CAGR of -4.1% during the review period. Fully considering the economic change by this health crisis, Gels accounting for % of the Testosterone Replacement Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Global Testosterone Replacement Therapy Scope and Segment
Testosterone Replacement Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Testosterone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Gels
Injections
Patches
Other
Segment by Application
Hospitals
Clinics
Others
By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions